Recruiting
Phase 1

CD33Bi with Venetoclax

Sponsor:

University of Virginia

Code:

NCT07270978

Conditions

Acute Myeloid Leukemia

Myelodysplastic Syndromes

Myelodysplastic/Myeloproliferative Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CD33 FPBMC

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-22. This information was provided to ClinicalTrials.gov by University of Virginia on 2025-12-08.